申请人:Brookes S. Paul
公开号:US20060122267A1
公开(公告)日:2006-06-08
The present invention relates to a S-nitrosated mitochondria-targeted thiol-based antioxidant prodrug and uses therefore for the prevention or treatment of diseases or conditions associated with mitochondrial dysfunction resulting from changes in the mitochondrial redox environment. When activated, prodrug of the present invention can specifically provide a NO
•
donor and a thiol-based antioxidant to mitochondria thereby decreasing the degree of mitochondrial dysfunction.